Dr. Karin Knobe, dressed in a suit with a lanyard, is standing in a medical conference booth that has images of red blood cells; on the left, there is text that says “We chase the miracles of science to improve people’s live”; on the right, there is text that says “Rare Blood Disorders.”

Easing Hemophilia Burden: From Disease to Treatment

Dr. Karin Knobe, Head Rare Diseases Clinical Development, has seen firsthand the impact hemophilia has on a person from her days as a practicing pediatric hematologist. Learn how she is taking those learnings to make sure future innovations help address both the burden of disease and treatment.

Jennifer Bahun smiles at the camera in a traditional headshot.

Empowering the Next Generation Through Mentorship

This Women's History Month, Sanofi employee and 2024 Social Impact Award winner, Jennifer Bahun shares her passion for mentorship, reflecting on her own experiences and how she is still learning from her mentees all these years later.

A mother and father smile with their three children.

For My Family, RSV Protection Was Never a Question

Learn about Jessica Pansini’s motivation to help protect her youngest child from respiratory syncytial virus (RSV) after her daughter contracted the virus at 5 months old.

Listening and Learning: Advancing Equity in Rare Disease Care

Sanofi colleagues share their personal experiences living with, or caring for someone living with, a rare disease. Hear some of their thoughts, hopes, and challenges, from the fear of the unknown to the everyday struggles. These stories shed light on what life is really like with a rare disease and highlight the strength and resilience of the rare disease community.

Latest News


March 28, 2025
Qfitlia approved as the first therapy in the US to treat hemophilia A or B with or without inhibitors

March 26, 2025
Chlamydia vaccine candidate granted fast track designation by the US FDA

March 25, 2025
Tolebrutinib regulatory submission accepted for priority review in the US for patients with multiple sclerosis

Explore More

Stephane Poirier in lab gear testing samples at his lab.

Fourth Quarter & Full Year 2024 Results

January 30, 2025

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community. The presentation was followed by a Q&A session.

Sanofi’s 2025 Pricing Principles Report

Sanofi’s 2025 Pricing Principles Report underscores our commitment to fostering a culture of transparency in the healthcare system and advocating for policies that make our treatments accessible and affordable to those in need.

A Million Conversations

People need healthcare systems – at all levels – to better reflect society. So we must listen to marginalized communities more and use those insights to help the healthcare industry, policymakers and governments to fix the causes of these trust gaps.

Pursue Progress. Discover Extraordinary. 

Better is out there. Better medications, better outcomes, better science. It's all down to people like you, from different backgrounds, in different locations, doing different roles. Take the most important step in your career: help us change the lives of people, families and communities for the better.

MAT-US-2014105-v8.0-01/2024